» Articles » PMID: 8889347

A Note on Quantifying Follow-up in Studies of Failure Time

Overview
Publisher Elsevier
Date 1996 Aug 1
PMID 8889347
Citations 967
Authors
Affiliations
Soon will be listed here.
Citing Articles

Urinary Catecholamines Predict Relapse During Complete Remission in High-Risk Neuroblastoma.

Matser Y, Samim A, Fiocco M, van de Mheen M, van der Ham M, de Sain-van der Velden M JCO Precis Oncol. 2025; 9:e2400491.

PMID: 39983076 PMC: 11867808. DOI: 10.1200/PO-24-00491.


Assessing the impact of telehealth on blood glucose management among patients with diabetes: a systematic review and meta-analysis of randomized controlled trials.

Getie A, Amlak B, Ayenew T, Gedfew M BMC Health Serv Res. 2025; 25(1):285.

PMID: 39979923 PMC: 11840977. DOI: 10.1186/s12913-025-12401-9.


Patterns and outcomes of current antitumor therapy for high-grade neuroendocrine neoplasms: perspective of a tertiary referral center.

Melhorn P, Spitzer J, Adel T, Wolff L, Mazal P, Raderer M J Cancer Res Clin Oncol. 2025; 151(2):86.

PMID: 39971811 PMC: 11839849. DOI: 10.1007/s00432-025-06126-9.


Disparities in utilization of novel cancer therapies in advanced stage III and IV melanoma and variance in outcomes.

Ali M, Ahn J, Espat N, Calvino A, Koness J, Somasundar P Immunotherapy. 2025; 17(1):37-46.

PMID: 39825755 PMC: 11834448. DOI: 10.1080/1750743X.2025.2452836.


Long-term survival of participants in the PASART-1 and PASART-2 trials of neo-adjuvant pazopanib and radiotherapy in soft tissue sarcoma.

Van Riet B, Van Meekeren M, Fiocco M, Miah A, De Pree I, Wiltink L Acta Oncol. 2025; 64():69-77.

PMID: 39813174 PMC: 11758146. DOI: 10.2340/1651-226X.2025.42333.